Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    opt-80
Show Display Options
Rank Status Study
1 Completed A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Condition: Clostridium Difficile
Interventions: Drug: OPT-80;   Drug: vancomycin
2 Completed OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
Condition: Diarrhea
Intervention: Drug: OPT-80
3 Completed
Has Results
PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
Conditions: Clostridium Infections;   Diarrhea
Interventions: Drug: PAR-101/OPT-80;   Drug: Vancomycin
4 Completed
Has Results
Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Condition: Clostridium Difficile-associated Diarrhea
Intervention: Drug: fidaxomicin
5 Completed A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
Conditions: Pharmacokinetics of Fidaxomicin;   Healthy Subjects
Interventions: Drug: Fidaxomicin;   Drug: Placebo
6 Completed
Has Results
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)
Condition: Clostridium Difficile-Associated Diarrhea (CDAD)
Interventions: Drug: fidaxomicin;   Drug: Placebo
7 Not yet recruiting A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections
Condition: Clostridium Difficile Infection (CDI)
Interventions: Drug: Fidaxomicin;   Drug: Vancomycin
8 Completed
Has Results
Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)
Conditions: Clostridium Infections;   Diarrhea
Interventions: Drug: Fidaxomicin;   Drug: Vancomycin;   Drug: Matching Placebo to Fidaxomicin
9 Completed Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)
Conditions: Inflammatory Bowel Disease (IBD);   Clostridium Difficile Infection (CDI)
Intervention: Drug: fidaxomicin

Study has passed its completion date and status has not been verified in more than two years.